State governor says UAB’s precision medicine center will ‘stimulate major strides in science and medicine and serve as a wise investment with a great return.’
The adoption of a precision medicine program by such a large insurer is expected to significantly expand the availability of precision medicine options within the state.
Blue Care Network of Michigan to Launch Pharmacogenomic Personalized Medicine Program Read More »
Because of the increased number of risk adjustment programs, improved diagnosis and treatment of chronic kidney disease (CKD) could trigger substantial financial benefit. This research maps a path for physicians and health systems to better utilize existing medications for their patients with CKD.
Two distinct entities will be created. The capabilities of the new US-Isaeli international partnership model are predicted to be a boon for oncologists and cancer therapeutics developers. It aims to untangle “medical mysteries in patients …”
Although Genomic Testing Cooperative’s agreement with New Jersey-based Hackensack Meridian Health is in its early stages, what is learned from the unique co-op model agreement will be useful for hospital and health system leaders who are evaluating precision medicine approaches.
